This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knapp, C C
Right arrow Articles by Washington, J A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knapp, C C
Right arrow Articles by Washington, J A, 2nd

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1986 December; 30(6): 938-939

Antistaphylococcal activity of a cyclic peptide, LY146032, and vancomycin.

C C Knapp and J A Washington 2nd

ABSTRACT

The inhibitory and bactericidal activities of a novel cyclic peptide antibiotic, LY146032, and vancomycin against oxacillin-susceptible and oxacillin-resistant staphylococci were compared. The MICs for 90% of strains were two- to fourfold higher for vancomycin than for LY146032. MBC/MIC ratios for all strains were less than or equal to 2. In killing rate studies with four strains of staphylococci, there was no detectable growth in the presence of 4X the MIC of either LY146032 or vancomycin after 24 h of incubation.

Antimicrob Agents Chemother. 1986 December; 30(6): 938-939




This article has been cited by other articles:

  • Safdar, N., Andes, D., Craig, W. A. (2004). In Vivo Pharmacodynamic Activity of Daptomycin. Antimicrob. Agents Chemother. 48: 63-68 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»